Physician profile
Alan Cowan
NPI 1013111673
$1,293.97
in general payments reported to CMS, 2019-2025
15 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.59 · 2020: $29.22 · 2021: $100 · 2022: $243 · 2023: $31.31 · 2024: $335 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $459.17 | 2024-2025 | Inspire |
| Stryker Corporation | $211.84 | 2019-2024 | Audion Et Dilation System |
| Regeneron Healthcare Solutions, INC. | $178.55 | 2021-2025 | Dupixent |
| Genzyme Corporation | $160.54 | 2021-2025 | |
| Intersect Ent, INC. | $51.80 | 2020-2022 | |
| Phadia US INC. | $43.55 | 2024 | Immunocap |
| Virtus Pharmaceuticals LLC | $38.06 | 2021 | |
| Aerin Medical INC. | $31.04 | 2019 | |
| Smith+Nephew, INC. | $28.86 | 2019 | |
| Acclarent, INC | $18.26 | 2019 | |
| Abbvie INC. | $17.64 | 2022 | |
| Agile Therapeutics, INC. | $15.72 | 2022 | |
| Itamar Medical INC | $15.39 | 2022 | |
| Medtronic, INC. | $12.20 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Cowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.